Impaired physical mobility Nursing care plan
Impaired physical mobility Nursing care plan
How to complete Impaired physical mobility Nursing care plan
Impaired physical mobility TEMPLATE
STUDENT’S NAME: CLINICAL UNIT: NEURO
DATE OF PATIENT CARE: CLINICAL INSTRUCTOR:
- DEMOGRAPHIC DATA:
Patient Initials: GM Age: Gender: Male Date of Admission: Disposition (DNR/Full Code): CPR
HISTORY OF PRESENT ILLNESS:
GM was brought to the hospital after being involved in a bar fight with a friend. The patient was hit on the back of his head and hit the ground. He was intoxicated during the ordeal and had to be brought in by two friends.
DIAGNOSIS: Impaired physical mobility related to neuromuscular impairment as evidence by right sided weakness.
ALLERGY: N/A REACTION: N/A
- PAST MEDICAL/ PSYCHIATRIC HISTORY (Include date condition was diagnosed, if known):
- PAST SURGICAL HISTORY (Include dates of surgery, if known):
III. PSYCHOSOCIAL HISTORY:
Spiritual/ Cultural Assessment
Reproductive Assessment
Menstrual assessment
LNMP: N/A
Smoking:
Recreational Drug us:
Influenza Vaccination:
Pneumovax:
Discharge Planning:
Support Systems:
Living arrangements:
Caregiver:
Referral Needs:
Medication Compliance Issues (literacy/language barrier etc.):
- VITAL SIGN
BP- Heart Rate – Heart Rhythm – Atrial Fibrillation: , Respiratory Rate: , Temp. –, O2 Sat –
- PAIN (Provide a complete description):
- Lab Values: Date of Result 9/25/22 (indicate if value is high or low):
Hemoglobin –14:
Na – 139:
BUN – 18:
PT – 9:
Hematocrit – 44%:
K – 4.0:
Creatinine – 1:
INR -1.1:
WBC – 13,000:
CO2 – 26: Normal
Glucose – 132:
PTT – 26:
Platelets – 200,000:
CL – 101:
Fingerstick – 26:
Albumin – 3.6:
Magnesium – 2.2:
Calcium – 9.9
Others: N/A
VII – Patient’s Medications (Include ALL medication the patient is taking, even if you did not administer. Use another sheet if needed)
Medication (as ordered by M.D./NP) – Classification – How does the medication work (Chemical action)? | Reason For Taking Them?
(Example: To treat Hypertension and CHF) |
Side Effects, contraindications and lab values to be monitored
(Only specific/important ones. Label items as below) |
Patient and Family Teaching
(Only specific instruction for that drug) Never write: Take as directed |
VIII. Nursing Care Plan – Provide any three nursing diagnosis.
Nursing Diagnosis
(What’s your patient’s most acute problem? |
Objectives / Goals
SMART criteria (Relate to your diagnosis) |
Interventions
(Minimum three, start with non-pharmacological care) |
Rationale
(Evidenced Based reasons for your interventions) |
Evaluation
(How do you know your interventions worked?) |
- Assessment Tools
Please provide the specific score for each of the following assessment tools and briefly state the significance of the score.
- Braden Score:
- Katz ADL Assessment:
- Hendrich II Fall Risk:
- Mini Cog (optional):
Note: If not able to assess, please write “unable to assess” and provide an explanation
SOLUTION: Impaired physical mobility Nursing care plan
STUDENT’S NAME: CLINICAL UNIT: NEURO
DATE OF PATIENT CARE: 10/04/2023 CLINICAL INSTRUCTOR:
- DEMOGRAPHIC DATA:
Patient Initials: GM Age: 52 , Gender: Male Date of Admission: 9/04/2023 Disposition (DNR/Full Code): CPR
HISTORY OF PRESENT ILLNESS:
GM was brought to the hospital after being involved in a bar fight with a friend. The patient was hit on the back of his head and hit the ground. He was intoxicated during the ordeal and had to be brought in by two friends. This happened two week ago.
DIAGNOSIS: Impaired physical mobility related to neuromuscular impairment as evidence by right sided weakness.
ALLERGY: N/A REACTION: N/A
- PAST MEDICAL/ PSYCHIATRIC HISTORY (Include date condition was diagnosed, if known):
The patient’s past medical history indicate that he has hypertension, neuromuscular disease, atrial fibrillation, and was involved in an accident 10 years ago where he suffered a spinal cord injury.
- PAST SURGICAL HISTORY (Include dates of surgery, if known):
No known history of surgery
III. PSYCHOSOCIAL HISTORY:
Spiritual/ Cultural Assessment
Religion: Muslim
Cultural/Ethnic background: Russian
Reproductive Assessment
Sexual orientation: Straight
Marital status: Married
Menstrual assessment
LNMP: N/A
Smoking: Has been smoking cigarette for the last 20 years. He smokes 45 packs per year.
Recreational Drug us: Takes alcohol occasionally
Influenza Vaccination: No
Pneumovax: No
Discharge Planning:
Support Systems: Discharge planning should include activities that will support the patient in ambulation, transferring, and movement in bed.
Living arrangements: _The patient should be encouraged to live downstairs to avoid risk for falls as one walks upstairs. Caregiver: A caregiver, especially the wife will provide the much needed support at home. Referral Needs: No need for referral
Medication Compliance Issues (literacy/language barrier etc.): the patient is literate and understands well the importance of medication compliance.
- VITAL SIGNS
BP- 165/87, Heart Rate – 121 /min, Heart Rhythm -105bpm, Atrial Fibrillation: 138bpm, Respiratory Rate: 20 /min, Temp. – 101 F , O2 Sat – 95 %
- PAIN (Provide a complete description): Sudden, sharp, and stabbing pain on his right side feet.
- Lab Values: Date of Result 9/25/22 (indicate if value is high or low):
Hemoglobin –14: Normal (Normal range 14-18g/dl)
Na – 139: Normal (Normal range136-145milimoles per liter)
BUN – 18: Normal (Normal range is 6-24mg/dL).
PT – 9: Low (Normal values 10-13 seconds)
Hematocrit – 44%: Normal (Normal range 40-54%)
K – 4.0: Normal (Normal range 3.5-5.2 mmol/L
Creatinine – 1: Normal (Normal range 0.7-1.3 mg/dL).
INR -1.1: Normal (Normal range is 1.1 and below)
WBC – 13,000: High (Normal range 4500-11000 WBCs per microliter
CO2 – 26: Normal (Normal range 23-30 mEq/L).
Glucose – 132: high (Normal values 70-100mg/dL).
PTT – 26: Normal (Normal values 25-35).
Platelets – 200,000: Normal (Normal range 150000-400000 platelets per microliter
CL – 101: Normal (Normal range 96-106 miliequivalent per liter
Fingerstick – 26: Low (Normal range 70-100mg/dL).
Albumin – 3.6: Normal (Normal range 3.4-5.4 g/dL).
Magnesium – 2.2: high (Normal 1.7-2.1 mg/dL).
Calcium – 9.9 Normal (Normal range 8.6-10.3 mg/dL).
Others: N/A
Height: 5ft 10 inches Weight: 160pds BMI (Compute based on patient’s height and weight): 22.96
VII – Patient’s Medications (Include ALL medication the patient is taking, even if you did not administer. Use another sheet if needed)
Medication (as ordered by M.D./NP) – Classification – How does the medication work (Chemical action)? | Reason For Taking Them?
(Example: To treat Hypertension and CHF) |
Side Effects, contraindications and lab values to be monitored
(Only specific/important ones. Label items as below) |
Patient and Family Teaching
(Only specific instruction for that drug) Never write: Take as directed |
Trade name: Enalapril
Generic name: Vasotec Classification: Angiotensin converting enzyme (ACE) inhibitors Mode of action: The medication works by blocking substances in the body that cause blood vessels to tighten. This result in the relaxation of blood vessels, lowers blood pressure, and increases supply of oxygenated blood to the heart and other body parts.
|
To reduce blood pressure | Side effects: Common side effects include hypotension, rapid fall in blood pressure, headache, dizziness, neutropenia, nausea, and stomach pain.
Contraindication: the medication should be avoided in patients with aortic stenosis, stroke, hypertrophic cardiomyopathy, renal artery stenosis, and renal impairment. Lab values: Some of lab values to be monitored include renal functioning, serum potassium levels, BUN, complete blood count, hypotension, and blood pressure. |
· Educate the patient how to identify adverse events such as hypotension, changes in skin colour, and turgor, and when to report to their primary care provider.
|
Trade name: Flecainide
Generic name: Sotalol Classification: Beta Blocker Mode of action: Flecainide works on fast-inward Na ion channels, prolongs depolarization, and increases refractoriness due to slow release from its binding site.
|
To treat irregular heart rhythm, shortness of breath, and atrial fibrillation
|
Side effects: Common serious side effects include dizziness, blurred vision, headache, muscle weakness, stomach pain, and constipation.
Contraindications: The drug is contraindicated in patients using fluconazole, HIV protease inhibitors, and anti-seizure medications. Lab values: Nurses should monitor the fasting blood glucose, blood pressure, serum concentration, and ketone levels to assess the effectiveness of the medication
|
· Educate the patients using sustained-release tablets to swallow whole and not chew or crush. · Nurses should educate the patient on the need to withdraw the medication immediately in case of acidosis.
|
Generic Name: Morphine Sulfate
Brand Names: Arymo ER, Kadian, MorphaBond ER, MS Contin Classification: Opioid agonists Mode of action: Binds to the mu-opioid receptor within the central nervous system and the peripheral nervous system thereby producing its analgesic effect.
|
To treat chronic pain due to spinal cord injury and impaired mobility caused as a result of a fall. | Side effects: The common adverse effects of the drug include constipation, central nervous system depression, nausea, skin rash, urticarial, bradycardia, vomiting, urinary retention, respiratory depression, sedation, dizziness, euphoria, agitation, dry mouth, anorexia, hypotension, and right upper quadrant pain.
Contraindications: contraindicated in patients with hypersensitivity to morphine and morphine extended release medications. The medication should also not be used in patients using MAOIs or those who have used these medications within the last 14 days. Lab Values: The patient should be monitored not to develop dependence, addiction, and drug abuse. Nurses should also assess the patient’s pain, respiration, blood pressure, mental status, consciousness, blood pressure, pulse rate, bowel function and urine output, constipation, and symptoms of hypotension.
|
|
Generic name: Pyridostigmine
Brand name: Mestinon Classification: Cholinesterase inhibitor Mode of action: Works by inhibiting the acetylcholinesterase (AChE) enzymes by breaking down the neurotrasmiter acetylcholine (ACh), thereby increasing the bioavailability of ACh and enhancing the transmission of nerve impulses at the neuromuscular junctions. |
To treat neuromuscular disease by improving transmission of nerve impulses and increasing muscle strength. | Side effects: Common side effects of this medication include diarrhea, vomiting, blurred vision, watery eyes, pale skin, and stomach upsets.
Contraindications: The drug is contraindicated in patients with asthma, cardiac arrhythmias, urinary tract obstruction, and GI obstruction. Lab values: No special lab values to monitor. However, one should assess for breathing, worsening muscle weakness, and excessive sweating. |
|
VIII. Nursing Care Plan – Provide any three nursing diagnosis.
Nursing Diagnosis
(What’s your patient’s most acute problem? |
Objectives / Goals
SMART criteria (Relate to your diagnosis) |
Interventions
(Minimum three, start with non-pharmacological care) |
Rationale
(Evidenced Based reasons for your interventions) |
Evaluation
(How do you know your interventions worked?) |
Risk for falls or injury related to decreased muscle strength, limited range of motion, and poor balance
|
The patient will display reduced falls by being able to ambulate, transfer, move in bed, and maintain balance.
|
1 Assess for factors that contribute to impaired mobility, risk for falls, and address them accordingly
2 Provide non-slip mats and rugs on the floor 3 Assist the patient to practice transfer by implementing strategies that are individualized to the patient’s needs.
|
|
|
Skin breakdown related to inability to ambulate, transfer, or move in bed
|
The patient will be able to participate in activities of daily living within 2 weeks
|
|
|
A reduction is skin breakdown and ability to ambulate |
Risk for infection and pain
|
The patient will verbalize a reduction in pain and absence of infections
|
|
|
|
- Assessment Tools
Please provide the specific score for each of the following assessment tools and briefly state the significance of the score.
- Braden Score: This scale is used to evaluate the patient’s risk for developing pressure ulcers. The scale is based on 6 items that encompass sensory perception, moisture, activity, mobility, nutrition, and friction and shear. Each category is rates based on a scale of 1-4 except that of friction and shear which is scored on a 1-3 scale. The highest score of 23 indicate no risk while the lowest possible score of 6 represent the severest risk for developing pressure ulcers.
Based on Braden scale, the patient has a score of 18 indicating mild risk for developing pressure ulcers.
- Katz ADL Assessment: This scale is critical in assessing basic activities of daily living. The scale analyzes the levels of dependence (Scale 0 point) and independence (scale 1 point) in six daily activities that include bathing, dressing, toileting, transferring, continence, and feeding (Wallace, 2007). A score of 6 indicate fully functional, 4 moderate impairment, and below 2 severe functional impairment (Wayne, 2023). Based on the functional level of the patient, his Katz ADL score is 4 indicating moderate level of impairment.
- Hendrich II Fall Risk: This scale is used to evaluate patients’ risk for falls. The scale explores some of the risk factors that result to falls such as dizziness, altered elimination, depression, confusion, ability to move in a single move among others. A score of 5 or greater indicates high risk for fall (Hendrich, 2012).
- Mini Cog (optional): Unable to assess since dementia cannot be assessed at its early stages.
Note: If not able to assess, please write “unable to assess” and provide an explanation
References
Braden, B. & Bergstrom, N. (1998). Braden scale for predicting pressure sore risk. Assessed on 28th July 2023 from https://www.in.gov/health/files/Braden_Scale.pdf
Hendrich, A. (2012). Fall risk assessment for older adults: The Hendrich II Fall risk model. Accessed on 28th July 2023 form http://www.wsha.org/wp-content/uploads/Hendrich-II-Fall-Risk.pdf
Wagner, M. (2023). Impaired physical mobility nursing diagnosis and care. https://www.nursetogether.com/impaired-physical- mobility-nursing-diagnosis-care- plan/#:~:text=Nursing%20Assessment%20for%20Impaired%20Physical,that%20can%20prevent%20purposeful%20movemen t.
Wallace, M. (2007). Katz index of independence in activities of daily living (ADL). Assessed on 28th July 2023 from https://www.alz.org/careplanning/downloads/katz-adl.pdf
Wayne, G. (2023). Physical mobility and immobility care plan and management. https://nurseslabs.com/impaired-physical-mobility